An annual report from China’s Ministry of Commerce describes a faster pace of consolidation in the distribution sector, but prolonged challenges for retailers.
BEIJING – China’s three biggest pharmaceutical distributors gobbled up nearly one-third of total drug distribution revenues in 2011, and their market shares continue to rise. In comparison, strong headwinds have prompted small drugstore chains to form alliances to share platforms and save costs, China’s Ministry of Commerce (MOFCOM) said.
Overall, Chinese wholesale and retail pharmaceutical sales grew 23% to RMB 942 billion ($151 billion) in 2011. There were a...
Novo Nordisk debuts Wegovy in India, gears for pole position in obesity. The Danish group’s leadership doesn’t appear too perturbed about the head start for Lilly’s Mounjaro or the imminent arrival of generic semaglutide next year.
After the failure of its lead asset in a Phase II trial earlier this year, Korea's Bridge Biotherapeutics has accepted an acquisition offer from bitcoin group Parataxis.
Multiple Chinese firms presented at this year’s ADA meeting, with a focus on weight reduction efficacy for mostly early clinical stage assets. While limited information was given on lean mass preservation, several companies are progressing drugs and combos to address this need.
